Association study of PDE4B with panic disorder in the Japanese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 545-549

  Otowa, Takeshi ^a,b   Kawamura, Yoshiya ^a   Sugaya, Nagisa ^c   Yoshida, Eiji ^d   Shimada, Takafumi ^a   Liu, Xiaoxi ^a   Tochigi, Mamoru ^a   Umekage, Tadashi ^a   Miyagawa, Taku ^a   Nishida, Nao ^a   Kaiya, Hisanobu ^d,e   Okazaki, Yuji ^f   Tokunaga, Katsushi ^a   Sasaki, Tsukasa ^g  

^a UNIVERSITY OF TOKYO   (Japan)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASEDA UNIVERSITY   (Japan)

^d Akasaka Mental Clinic   (Japan)

^e Nagoya Mental Clinic   (Japan)

^f TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

Association; Japanese population; Panic disorder; Phosphodiesterase 4B (PDE4B); Single nucleotide polymorphism

Indexed keywords

ANTIDEPRESSANT AGENT; GENOMIC DNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE IVB; ROLIPRAM; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PANIC; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANXIETY DISORDERS; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MOLECULAR TARGETED THERAPY; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 79952898307     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.013     Document Type: Article

References (37)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
2. Berksun O.E. Panic disorder and memory: does panic disorder result from memory dysfunction?. Eur Psychiatry 1999, 14:54-56.
3. Blockland A., Schreiber R., Prickaerts J. Improving memory: a role for phosphodiesterases. Curr Pharm Des 2005, 11:3329-3334.
4. Bolger G., Michaeli T., Martins T., St John T., Steiner B., Rodgers L., et al. A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol 1993, 13:6558-6571.
5. Charney D.S., Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996, 10:419-446.
6. Cherry J.A., Davis R.L. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 1999, 407:287-301.
7. Cherry J.A., Thompson B.E., Pho V. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Biochim Biophys Acta 2001, 1518:27-35.
8. Crowe R.R., Noyes R., Pauls D.L., Slymen D. A family study of panic disorder. Arch Gen Psychiatry 1983, 40:1065-1069.
9. Davis R.L., Cherry J., Dauwalder B., Han P.L., Skoulakis E. The cyclic AMP system and Drosophila learning. Mol Cell Biochem 1995, 149-150:271-278.
10. Dlaboga D., Hajjhussein H., O'Donnell J.M. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram. Brain Res 2006, 1096:104-112.
11. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008, 66:87-98.
12. Eaton W.W., Kessler R.C., Wittchen H.U., Magee W.J. Panic and panic disorder in the United States. Am J Psychiatry 1994, 151:413-420.
13. Fatemi S.H., King D.P., Reutiman T.J., Folsom T.D., Laurence J.A., Lee S., et al. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 2008, 101:36-49.
14. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
15. Goldstein R.B., Wickramaratne P.J., Horwath E., Weissman M.M. Familial aggregation and phenomenology of 'early'-onset (at or before age 20years) panic disorder. Arch Gen Psychiatry 1997, 54:271-278.
16. Hettema J.M., Neale M.C., Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001, 158:1568-1578.
17. Huston E., Lumb S., Russell A., Catterall C., Ross A.H., Steele M.R., et al. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem J 1997, 328:549-558.
18. Kähler A.K., Otnaess M.K., Wirgenes K.V., Hansen T., Jönsson E.G., Agartz I., et al. Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:86-96.
19. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. Panic disorder in women: a population-based twin study. Psychol Med 1993, 23:397-406.
20. Li Y.F., Huang Y., Amsdell S.L., Xiao L., O'Donnell J.M., Zhang H.T. Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 2009, 34:2404-2419.
21. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
22. Maron E., Hettema J.M., Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010, 15:681-701.
23. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000, 9:1415-1423.
24. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
25. Numata S., Ueno S., Iga J., Song H., Nakataki M., Tayoshi S., et al. Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population. J Psychiatr Res 2009, 43:7-12.
26. Numata S., Iga J., Nakataki M., Tayoshi S., Taniguchi K., Sumitani S., et al. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:527-534.
27. O'Donnell J.M., Frith S. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacol Biochem Behav 1999, 63:185-192.
28. Pandey S.C., Zhang H., Roy A., Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 2005, 115:2762-2773.
29. Panguluri R.C., Long L.O., Chen W., Wang S., Coulibaly A., Ukoli F., et al. COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis 2004, 25:961-966.
30. Pickard B.S., Thomson P.A., Christoforou A., Evans K.L., Morris S.W., Porteous D.J., et al. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 2007, 17:129-133.
31. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
32. Rose G.M., Hopper A., De Vivo M., Tehim A. Phosphodiesterase inhibitors for cognitive enhancement. Curr Pharm Des 2005, 11:3329-3334.
33. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59. Suppl;20:22-33.
34. Silvestre J.S., Fernandez A.G., Palacios J.M. Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. J Psychopharmacol 1999, 13:274-277.
35. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997, 54:305-309.
36. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008, 83:445-456.
37. Zhang H.T. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des 2009, 15:1688-1698.